LIDOCAINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lidocaine Hydrochloride, and what generic alternatives are available?
Lidocaine Hydrochloride is a drug marketed by Abbott, Abraxis Pharm, Afaxys, Am Regent, Aspiro, B Braun Medical Inc, Bel Mar, Belmora Llc, Dell Labs, Elkins Sinn, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Huons, Intl Medication, Luitpold, Lyphomed, Mankind Pharma, Miles, Rising, Sintetica Us, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Cosette, Sentiss, Watson Labs Inc, Hikma, Rubicon, Wockhardt Bio Ag, Lannett Co Inc, Novitium Pharma, Paco, Pai Holdings Pharm, Taro, Baxter Hlthcare, B Braun, Eastman Kodak, Empi, Mylan Labs Ltd, Actavis Mid Atlantic, and Chartwell Molecular. and is included in one hundred and nine NDAs.
The generic ingredient in LIDOCAINE HYDROCHLORIDE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for LIDOCAINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 45 |
NDAs: | 109 |
Finished Product Suppliers / Packagers: | 37 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Clinical Trials: | 1,780 |
Patent Applications: | 5 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in LIDOCAINE HYDROCHLORIDE? | LIDOCAINE HYDROCHLORIDE excipients list |
DailyMed Link: | LIDOCAINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Arkansas Children's Hospital Research Institute | Phase 4 |
Universitas Sebelas Maret | Phase 4 |
Indonesia Endowment Fund for Education | Phase 4 |
Pharmacology for LIDOCAINE HYDROCHLORIDE
Drug Class | Amide Local Anesthetic Antiarrhythmic |
Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for LIDOCAINE HYDROCHLORIDE
US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 080377-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
B Braun | LIDOCAINE HYDROCHLORIDE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER | lidocaine hydrochloride | INJECTABLE;INJECTION | 018967-002 | Mar 30, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 083158-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Fresenius Kabi Usa | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 080404-003 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bel Mar | LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 080757-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |